F Soliotis, M Glover, A S M Jawad. Show Affiliations »
Abstract
Entities: Chemical Disease Species
Mesh: See more » AdultArthritis, Rheumatoid/drug therapyArthritis, Rheumatoid/pathologyDrug Eruptions/etiologyDrug Eruptions/pathologyErythema/chemically inducedEtanerceptFemaleHumansImmunoglobulin G/adverse effectsImmunoglobulin G/therapeutic useIsoxazoles/adverse effectsIsoxazoles/therapeutic useLeflunomidePyrimidines/antagonists & inhibitorsReceptors, Tumor Necrosis Factor/therapeutic useTumor Necrosis Factor-alpha/antagonists & inhibitors
Substances: See more » Immunoglobulin GIsoxazolesPyrimidinesReceptors, Tumor Necrosis FactorTumor Necrosis Factor-alphaLeflunomidepyrimidineEtanercept
Year: 2002 PMID: 12176818 PMCID: PMC1754223 DOI: 10.1136/ard.61.9.850
Source DB: PubMed Journal: Ann Rheum Dis ISSN: 0003-4967 Impact factor: 19.103